AbbVie logo

AbbVie

North America, Illinois, United States, North Chicago

Description

AbbVie is a pharmaceutical company that discovers, develops, and markets medicines.

Investor Profile

AbbVie has made 23 investments, with 3 in the past 12 months and 35% as lead.

Stage Focus

  • Grant (57%)
  • Series A (17%)
  • Corporate Round (13%)
  • Series Unknown (4%)
  • Series C (4%)
  • Seed (4%)

Country Focus

  • United States (87%)
  • Switzerland (4%)
  • France (4%)
  • Denmark (4%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Non Profit
  • Pharmaceutical
  • Health Diagnostics
  • Mental Health
  • Hospital
  • Therapeutics
  • Wellness
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does AbbVie frequently co-invest with?

Direct Relief
North America, California, United States, Santa Barbara
Co-Investments: 10
Alexandria
North America, California, United States, San Francisco
Co-Investments: 3
HA
North America, New York, United States, New York
Co-Investments: 2
Accelerator Life Science Partners
North America, New York, United States, New York
Co-Investments: 2
Partnership Fund for New York City
North America, New York, United States, New York
Co-Investments: 2
Johnson & Johnson Robotics and Digital Solutions
North America, New Jersey, United States, New Brunswick
Co-Investments: 2
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 2
Empire State Development
North America, New York, United States, New York
Co-Investments: 2
Eli Lilly
North America, Indiana, United States, Indianapolis
Co-Investments: 2
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 2

What are some of recent deals done by AbbVie?

Syndeio Biosciences

Indianapolis, Indiana, United States

Syndeio Biosciences is a newly launched biotech company pioneering precision neurotherapeutics.

Biotechnology
Series UnknownMay 27, 2025
Amount Raised: $90,000,000
ThirtyFiveBio

Abingdon, Oxfordshire, United Kingdom

ThirtyFiveBio is a biotechnology agency

Biotechnology
Series UnknownApr 15, 2025
Cephagenix

Glostrup, Hovedstaden, Denmark

Cephagenix focuses on identifying and developing new, effective migraine therapies.

Health CareHealth DiagnosticsMedicalWellness
SeedJan 16, 2025
Amount Raised: $9,259,669
Light Horse Therapeutics

San Diego, California, United States

Light Horse Therapeutics is a small molecule drug discovery, pioneering to target that causes disabling and life-threatening diseases.

Biotechnology
Series AJan 9, 2025
Amount Raised: $62,000,000
BaseLaunch

Allschwil, Basel-Landschaft, Switzerland

The BaseLaunch accelerator is tailored to the needs of healthcare startups.

Biotechnology
Corporate RoundMay 22, 2024
Capsida

Newbury Park, California, United States

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders.

BiotechnologyGeneticsHealth Care
Corporate RoundFeb 23, 2023
Carisma Therapeutics

Philadelphia, Pennsylvania, United States

Carisma Therapeutics is a biotech company that develops novel chimeric antigen receptor macrophage technology to treat solid tumors.

BiotechnologyHealth CareLife ScienceMedicalTherapeutics
Series CSep 21, 2022
Amount Raised: $30,000,000
Eskenazi Health

Indianapolis, Indiana, United States

Eskenazi Health provides exceptional and comprehensive healthcare to Central Indiana.

Health Care
GrantAug 31, 2021
MLK Health Center

Shreveport, Louisiana, United States

MLK Health Center provides health care and pharmacy services.

Health CareHealth DiagnosticsMedicalPharmaceutical
GrantAug 31, 2021
Delaware Valley Community Health

Philadelphia, Pennsylvania, United States

Delaware Valley Community Health operates as a non-profit firm, the firm offers adult & family medicine, pediatrics, dental, etc. services.

Health CareNon Profit
GrantAug 31, 2021